<link rel="stylesheet" href="styles.f3b1fba60ec7970c.css">

Evaluation of treatment outcomes and tolerability in older patients with rectal cancer treated with radiotherapy accompanied by the G-8 geriatric score: TROD13-003 multicenter study

dc.contributor.authorGuzeloz, Zeliha
dc.contributor.authorGorken, lknur Bilkay
dc.contributor.authorAydin, Barbaros
dc.contributor.authorSert, Fatma
dc.contributor.authorYalman, Deniz
dc.contributor.authorParvizi, Murtaza
dc.contributor.authorMetcalfe, Evrim
dc.date.accessioned2026-10-09T21:48:01Z
dc.date.issued2024
dc.departmentYüksek İhtisas Üniversitesi
dc.description.abstractIntroduction: The choice of treatment for rectal cancer often differs in older and younger patients, with the rate of radiotherapy use lower among older adults. In our daily practice, when evaluating a frail older patient with rectal cancer, we usually choose to give less treatment. This may be due to concern that the patient will not be able to tolerate radiotherapy. The Geriatric 8 score (G8GS) is a guide to evaluating treatment tolerability as it relates to frailty in older adults with cancer. The aim of this study was to evaluate treatment outcomes and tolerability in older patients with rectal cancer treated with radiotherapy (RT) accompanied by G8GS. Materials and Methods: Patients aged 65 and older with stage I-III rectal adenocarcinoma who were treated with RT and had a G8 evaluation were included in this multicenter retrospective study. Prognostic factors related to G8GS were calculated using Chi-square and logistic regression tests and survival rates were calculated by the Kaplan -Meier test using the SPSS v24.0 software. All p -values <= 0.05 were considered statistically significant. Results: A total of 699 patients from 16 national institutions were evaluated. The median age was 72 years (range 65 -96), and the median follow-up was 43 (range 1190) months. Four hundred and fifty patients (64%) were categorized as frail with G8GS <= 14 points. Frail patients had higher ages ( p = 0.001) and more comorbidities (p = 0.001). Ability to receive concomitant and/or adjuvant chemotherapy rates were significantly higher in fit patients ( p = 0.002 and p = 0.001, respectively). No significant difference was observed in terms of grade 3-4 early and late toxicity for both groups. Cancer-related death was higher ( p = 0.003), and 5and 8-year survival rates were significantly lower (p = 0.001), in the frail group. Age and being frail were significantly associated with survival. Discussion: Radiotherapy is a tolerable and effective treatment option for older adults with rectal cancer even with low G8GS. Being in the frail group according to G8GS and having multiple comorbidities was negatively associated with survival. Addressing the medical needs of frail patients through a comprehensive geriatric assessment prior to radiotherapy may improve G8GS, allowing for standard treatment and increased survival rates.
dc.identifier.doi10.1016/j.jgo.2024.101739
dc.identifier.issn1879-4068
dc.identifier.issn1879-4076
dc.identifier.issue3
dc.identifier.orcid0000-0003-1036-2593
dc.identifier.orcid0000-0002-7819-2335
dc.identifier.orcid0000-0001-5970-6452
dc.identifier.orcid0000-0002-3182-8623
dc.identifier.pmid38492350
dc.identifier.scopus2-s2.0-85187997936
dc.identifier.scopusqualityQ2
dc.identifier.urihttps://doi.org/10.1016/j.jgo.2024.101739
dc.identifier.urihttps://hdl.handle.net/20.500.12794/3529
dc.identifier.volume15
dc.identifier.wosWOS:001220854300001
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.indekslendigikaynak.digerScience Citation Index Expanded (SCI-EXPANDED)
dc.language.isoen
dc.publisherElsevier
dc.relation.ispartofJournal of Geriatric Oncology
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.relation.sdgGoal-03: Good Health and Well-Being
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20260922
dc.subjectElderly-Patients
dc.subjectColorectal-Cancer
dc.subjectRadiation-Therapy
dc.subjectScreening Tools
dc.subjectPreoperative Chemoradiotherapy
dc.subjectPrognostic Value
dc.subjectRisk
dc.subjectComplications
dc.subjectChemotherapy
dc.subjectManagement
dc.titleEvaluation of treatment outcomes and tolerability in older patients with rectal cancer treated with radiotherapy accompanied by the G-8 geriatric score: TROD13-003 multicenter study
dc.typeArticle

Files